BioWorld - Friday, December 26, 2025

Analysis and data insight
Analysis and data insight RSS Feed RSS

Med-tech financings December 2023

$1B raised in December, but 2023 med-tech financings down 54%

Jan. 5, 2024
By Amanda Lanier
Med-tech financings exceeded $1 billion for the third consecutive month, reaching a total of $1.07 billion in transactions in December. In November, med-techs raised $1.02 billion, with $1.23 billion raised in October. The overall average for financings in 2023 stands at $1.47 billion per month, down from a monthly average of $3.19 billion the previous year.
Read More
Clinical data illustration
Biopharma clinical updates November 2023

BioWorld reports on 3,000+ clinical trial updates through November

Dec. 29, 2023
By Amanda Lanier
Clinical trial updates saw a 5.82% increase for the period of January to November 2023 compared to the same period last year. In November, BioWorld reported on 354 phase I-III trial updates. Although marking a decline from the 416 reported in October, the number of updates still surpasses the previous three months.
Read More
FDA Approved stamp
Biopharma regulatory actions and approvals November 2023

FDA nods remain up from last year, yet lag behind 2017-2021

Dec. 22, 2023
By Amanda Lanier
In November, the U.S. FDA approved a total of 12 drugs, a decrease from 27 the previous month that marked the highest number of approvals since June 2020, as reported by BioWorld. From January to November, FDA approvals reached 167, an increase of 21.9% from 137 drugs approved during the same time period the previous year.
Read More